Bio medical-polymers-and-polymer-therapeutics-2002-chiellini
UHPLC for Large Bio-Therapeutics - Thermo Fisher...
Transcript of UHPLC for Large Bio-Therapeutics - Thermo Fisher...
UHPLC for Large Bio-Therapeutics
1
The world leader in serving science
Ken Cook
EU Bio-separations Support Expert
June 2015
Various Types of Antibody-Based Therapeutics
Antibody-drug conjugateKadcyla (trastuzumab emtansine)
mAb Fab fragmentCimzia (certolizumab pegol)Lucentis (ranibizumab)
PEGylated mAbCimzia (certolizumab pegol)
2
Fusion proteinEnbrel (etanercept)TNF receptor-Fc fusion
Kadcyla (trastuzumab emtansine)Adcetris (brentuximab)
Bispecific mAbRemovab (catumaxomab)
Properties of Proteins
• Properties:
• Size
• Charge
• Hydrophobicity
+
++
--
-
3
• Hydrophobicity
• Affinity or Recognition +
+
+
-
--
Protein Separation by UHPLC
Ion Exchange Chromatography (IEX)
Size Exclusion Chromatography (SEC)
Size difference?
Charge difference?
Thermo Scientific™
MAbPac™ SEC-1 Column
Thermo Scientific™ ProPac™
WCX-10 ColumnMAbPac SCX-10 Column ProPac SAX-10 Column
4
Hydrophobic Interaction Chromatography (HIC)
Hydrophobicity difference?
Reverse Phase Chromatography (RPC)
MAbPac HIC-10 ColumnMAbPac HIC-20 ColumnMAbPac HIC-Butyl Column
MAbPac RP ColumnThermo Scientific™
ProSwift™ RP Column
• High resolution – small changes in a large molecule
• Speed – many variations to analyse and many potential drug candidates
• Robust analysis
• Global methods to reduce method development time
• Multidimensional possibilities
Requirements for Development of New Solutions
5
• Multidimensional possibilities
• New systems and new chemistries
Biopharma UHPLC Portfolio
Thermo Scientific ™
Dionex ™ UltiMate ™
3000 BioRS SystemEstablished
biocompatible UHPLC. Key benefit: Proven
Vanquish Flex System
Designed for allbiopharma labs. Key benefit: Flexibility
Thermo Scientific ™
Vanquish ™ System
Flagship system. Key benefit: High end
performance
6
Built for Biopharma
20142013 2015
2015 Systems for Bio-Therapuetic Analysis
High Resolution, Cooled Fractionation
7
Distribution of applications
20%
80%
Highly specific Workflows
Standard (biopharma) applications UltiMate 3000
BioRS system
pH and Conductivity
Vanquish Systems
System Biocompatibility by Default
UHPLC is now not limited to small moleculesBiomolecular analysis can benefit from the higher resolution and faster analysis this technique offers.
Thermo Scientific™ Viper™ Fingertight FittingsMP35N 100um i.d. Finger tight and zero dead volume.
Vanquish Parallel Binary PumpIndependent piston drives and variable stroke volume, 1500 bar. – ultra low baseline noise
LightPipe™ Technology in the Vanquish DAD Detector
8
LightPipe™ Technology in the Vanquish DAD Detector Provides you with an unmatched detection experience. Ultra-wide dynamic range, high sensitivity
SamplerZero maintenance ceramic injection valve, loop pre compression, 4 x 96 well plates, charger.
OvenAdiabatic and forced air. 30cm column, active eluent preheating, column switching, ceramic valves.
• Do a protein concentration assay
• Make up to 8M Urea
• Add DTT or TCEP at 70 C and wait for 30 minutes
• Make up Iodoacetate
• Add Iodoacetate and wait 15 minutes
• Dilute to 1 M Urea
In Solution Trypsin Digestion
9
• Dilute to 1 M Urea
• Make up Trypsin
• Add trypsin to vial and and wait for 4 hours
• Add more Trypsin and digest overnight
• Spin to remove particulates
• Possible SPE to remove detergents and Urea
Thermo Scientific Smart Trypsin Digestion
• Heat stable Trypsin
• 70 ºC heat denaturation of proteins so no need for detergents or urea
• Immobilized Trypsin in throw away PCR tube
• No autolysis
• Less steps and no clean up – much quicker and easier to use
10
• Less steps and no clean up – much quicker and easier to use
• Less modifications
• More reproducible
Undigested Protein RT: 0.00 - 30.02
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lativ
e A
bun
dan
ce
8.21575.80
9.08547.83
4.95395.65 7.15
464.70 9.17501.28
3.49441.13
14.92683.01
12.17657.02
10.53490.561.96
538.2613.62
672.57
≤ 90 ºC,≤60 Minutes
Filter LC/MS
Up to 96 Samples, ≤ 60 Minute No Pretreatment Necessary
11
0 2 4 6 8 10 12 14 16 18 20 22Time (min)
0
5
10
15
20
25
3017.23
802.27
19.36813.3115.38
812.42 21.321398.410.63
515.64 20.05823.40
17.78821.23
22.60974.78
• Complete digest of native protein in ≤ 60 minutes• Pretreatment (reduction and alkylation) – optional• Equipment required – thermal cycler• Multiple patents pending
Time for Digestion
Overall time for digestion is faster
Actual hands on preparation time is drastically reduced
Less repetitive manual steps reduces inaccuracy
12
Sample preparation
Protein assay
Digestion
SPE + dry/reconstitute
Spin down
Overlay of Different mAb Digests on the Vanquish System
13
Overlay of 10 Runs of a Trypsin Digest mAb with Retention Time Precision
peak #RT
(min)
RT-RSD (%)
3 3.315 0.0829 5.231 0.06514 6.532 0.01715 6.937 0.02319 10.290 0.02123 12.013 0.01231 14.011 0.01339 15.177 0.01242 15.589 0.010
14
42 15.589 0.01051 17.511 0.00755 17.969 0.01161 18.546 0.01083 20.798 0.01085 21.095 0.01287 22.386 0.00996 24.774 0.012
103 26.155 0.009106 26.155 0.009109 27.529 0.010
Slide 14
JH1 Please format with title-case text.Jim Hegarty; 15.10.2014
Peptide Maps of Herceptin Digest; 6-40min GradientsR
elat
ive
Abu
ndan
ce
Gra
dien
t tim
e to
30%
B /
tota
l run
tim
e
100
0100
0100
0
100
6/16 min6/16 min
8/16 min8/16 min
11/28 min11/28 min
15/28 min15/28 min
15
0 05 10 15 20 25 30 35 40 45 50 55 60
Rel
ativ
e A
bund
ance
Time (min)
Gra
dien
t tim
e to
30%
B /
tota
l run
tim
e
0100
0
100
0100
0
15/28 min15/28 min
20/38 min20/38 min
30/48 min30/48 min
40/60 min40/60 min
Can Use Shorter Gradients
Mechanism of Salt and pH Elution of Proteins
16
Comparison of pH Gradient Buffer Systems
In house buffer system 1 In house buffer system 2
0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 80.0 90.05.00
6.00
7.00
8.00
9.00
min
17
Thermo Scientific CX-1 pH 5.6 and 10.2 Phosphate based
0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 80.0 90.0
Re-equilibration Problems
8.00
8.50
9.00
9.50
10.00
10.50100.0
%C: 0.0 %
5 minutes re-equilibration on a 250mm columnThe ProPac WCX column buffers more against the programmed change in pH.The MAbPac SCX column equilibrates in timeThe ProPac WCX column does not get back down to the initial pH in time and is still dropping on injection
MAbPac SCX column
18
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0 19.0 20.0 21.05.00
5.50
6.00
6.50
7.00
7.50
min
21
Flow: 300 µ l/min
%B: 0.0 % 0.0
MAbPac SCX column
ProPac WCX column
Time to equilibrate is different
ProPac WCX is still not at the correct pH on time of injection
Improving Charged Variant Analysis
• Speed of analysis – 60min to 6min or below?
• Resolution – No loss in resolution
• Time to develop the method
• Global applicability
• Robustness
19
• Robustness
Generic Linear pH Gradient with the Vanquish System
MAB 1
MAB 2
MAB 3
20
pH 5.6 to 10.2 in 10 minutes
MAB 3
MAB 4
MAB 5
Slide 20
JH3 Please format with title-case text.Jim Hegarty; 15.10.2014
Example 1/5: Cetuximab – Vanquish System Fast Gradients
10 min gradient
5 min gradient
21
Number of charge variants and resolution maintained for 2.5 min gradient
3 steps method development1. 10 minutes 0�100% B in 10 minutes
2. 10�35% B in 5 minutes
3. 10�35% B in 2.5 minutes
2.5 min gradient
Example 2/5: Infliximab – Vanquish System Fast Gradients
10 min gradient
5 min gradient
22
Number of charge variants and resolution maintained for sub-minute gradient
3 steps method development1. 10 minutes 0�100% B in 10
minutes
2. 20�40% B in 5 minutes
3. 18�27% B in 0.8 minutes
0.8 min gradient
Hydrophobic Interaction Chromatography
Column: MAbPac HIC-10, 4.6 ×100 mmCompetitor A (Ether), 7.5 ×75 mm Competitor B (Butyl), 4.6 ×100 mm
Mobile phase A: 2.0 M ammonium sulfate, 100 mMsodium phosphate, pH 7.0
Mobile phase B: 100 mM sodium phosphate, pH 7.0Gradient:
Time (min) %A %B-5.0 60 400.0 60 401.0 60 40
15.0 0 10020.0 0 100
45
Abs
orba
nce
(mA
U)
Competitor A (Ether)
23
20.0 0 100
Temperature: 30 ºCFlow rate: 1.0 mL/minInj. volume: 2 µL (4 mg/mL)
Competitor A (Ether): 4 µL Detection: UV (280 nm)Sample: mAb
0 4 8 12 16 20
0
Retention Time (min)
Abs
orba
nce
(
Competitor B (Butyl)
Competitor A (Ether)
MAbPac HIC-10 Column
Global Analysis of Intact mAbs
30
40
50
60
Column: MAbPac HIC-10, 5 µmFormat: 4.6 ×100 mmMobile phase A: 2.0 M ammonium sulfate, 100
mM sodium phosphate, pH 7.0Mobile phase B: 100 mM sodium phosphate, pH
7.0Gradient:
Time (min) %A %B-5.0 60 400.0 60 401.0 60 40
15.0 0 10020.0 0 100
Abs
orba
nce
(mA
U)
24
0 4 8 12 16 20
0
10
20
20.0 0 100
Temperature: 30 ºCFlow rate: 1.0 mL/minInj. volume: 2 µL (4 mg/mL)Detection: UV (280 nm)Sample: mAb1
mAb2mAb3mAb4mAb5
Abs
orba
nce
Retention Time (min)
Aggregate Screening using MAbPac SEC-1 Column
25
HIC separation of MAb and Purified Dimer
26
Purified Dimer
mAb Sample with Aggregates
Method Speed up of Mab Aggregates with HIC
Column: MAbPac HIC-10, 5 μm
Format: 4.6 ×100 mm
Mobile Phase A: 2 M ammonium sulfate, 100 mM
sodium phosphate, pH 7.0
Mobile Phase B: 100 mM sodium phosphate, pH 7.0
Gradient (a Time (min) %A %B
-5.0 60 40
0.0 60 40
1.0 60 40 15.0 0 100
20.0 0 100
Gradient (b) Time (min) %A %B
-5.0 60 40
0.0 60 40
27
0.0 60 40
1.0 60 40
29.0 0 100
34.0 0 100
Flow rate: (a) 1.0 mL/min
(b) 0.5 mL/min
Inj. Volume: 10 μL (4 mg/mL)
Temp.: 30 ºC
Detection: UV (280 nm)
Separation of Cys-Linked ADC on MAbPac HIC-Butyl
Column: MAbPacHIC-Butyl, 5 µmFormat: 4.6 ×100 mmMobile phase A: 1.5 M ammonium sulfate, 50
mM sodium phosphate, pH 7.0 / isopropanol (95:5 v/v)
Mobile phase B: 50 mM sodium phosphate, pH 7.0 / isopropanol (80:20 v/v)
Gradient:Time (min) %A %B-5.0 100 00.0 100 01.0 100 0
15.0 0 100
20
30
40
Abs
orba
nce
(mA
U)
DAR 2
DAR 4
28
15.0 0 10020.0 0 100
Temperature: 25 ºCFlow rate: 1.0 mL/minInj. volume: 5 µL (5 mg/mL)Detection: UV (280 nm)Sample: Cys-conjugated ADC mimic
0 4 8 12 16 20
0
10
Abs
orba
nce
(
Retention Time (min)
DAR 0
DAR 6
DAR 8
6 min gradient, MAbPac RP Column with ADC Mimic
10.0
15.0
20.0
25.0 2 - MABPACRP_2PT1X50_BETA01 #35 HER-MMAE UV_VIS_1mAU WVL:280 nm
55.0
0.1% TFA + 70% IPA + 20% MeCN: 0.0 %
Peak 1: 0 MMAE, 2.04%Peak 2: 1 MMAE, 3.89%Peak 3: 2 MMAE, 3.94%Peak 4: 2 MMAE (isomer), 8.89%Peak 5: 3 MMAE, 25.11%Peak 6: 4 MMAE, 55.73%
29
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00-5.0
0.0
5.0
10.0
min
2
1
Flow: 600 µ l/min
0.1% TFA + 9.9% H2O + 90% MeCN: 35.0 % 35.0
HER
HER-MMAE
Peak 6: 4 MMAE, 55.73%
400
600
800
Cetuximab Separation on a MABPac RP Reverse Phase Column
30
0.0 1.3 2.5 3.8 5.0 6.3 7.5 8.8 10.0 12.0-100
200
400
min
Accurate Monoisotopic Mass Measurement Using Ultra High Resolution
LC-MS of Antibody Light Chain and Heavy Chain
+23
1005.5 1006.0 1006.5 1007.0 1007.5m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bun
danc
e
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
926.0595z=25
890.4806z=26 964.5199
z=24
857.5000z=27
1006.4988z=23
1102.3079z=211052.2487
z=22
798.5352z=29
1157.3224z=20771.8840
z=30 1218.1823 45
50
55
60
65
70
75
80
85
90
95
100
Rel
ativ
e A
bund
ance
G0F G1F+45
+45
+45 G1F
+45
1135.0 1135.2 1135.4 1135.6 1135.8 1136.0 1136.2 1136.4 1136.6 1136.8 1137.0m/z
0
10
20
30
40
50
60
70
80
90
100
Rel
ativ
e A
bund
ance
31
Q Exactive Plus MS, 280K, protein modeThermo Scientific Q Exactive ™ Plus MS, 140K
0.7 ppm
800 900 1000 1100 1200 1300 1400m/z
0
10
20
30 z=30 1218.1823z=19
1285.9696z=18 1361.4380
z=17
m/z
G0F G1F
G2F
2.3 ppm 1.8 ppm
20.2 ppm
1126 1128 1130 1132 1134 1136 1138 1140 1142 1144 1146m/z
0
5
10
15
20
25
30
35
40Rel
ativ
e A
bund
ance
G2F+45
System Configuration for Multiple Chemistries
UV
A B C
DGPRightDGPLeft
A B C
WPS
Dual gradient pump‘Two LPG pumps in a single unit’
(upgradeable with solvent selection valves)
Fraction collecting autosampler‘inject – collect – re-inject’
Column oven with column selection valvesup to 6 or 10 columns / positions Injection
collection
32
UV WPS collection Waste
SEC
IEC
Prot A
Wide Range of Bio Analytical UHPLC Characterization Methods
2 minutes 60 minute digest 0.00 0.13 0.25 0.38 0.50 0.63 0.75 0.88 1.00 1.13 1.25 1.37 1.50 1.62 1.75 1.87 2.00 2.12 2.25 2.37 2.50 2.62 2.75 2.87 3.00
-200
0
125
250
375
500
625
750
875
1,000
1,125
1,250
1,375
1,600 PHILOGEN #4 IgG UV_VIS_1mAU
min
WVL:280 nm
Flow: 1000 µ l/min
%B: 0.0 %
100.0
0.0
%C: 0.0 %
mAb Capture Peptide Mapping Glycan Analysis
33
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00-5.0
0.0
5.0
10.0
15.0
20.0
25.0 2 - MABPACRP_2PT1X50_BETA01 #35 HER-MMAE UV_VIS_1mAU
min
2
1
WVL:280 nm
Flow: 600 µ l/min
0.1% TFA + 9.9% H2O + 90% MeCN: 35.0 %
55.0
35.0
0.1% TFA + 70% IPA + 20% MeCN: 0.0 %
2 minutes 6 minutes4 minutes
ADC AnalysisCharged Variant AnalysisAggregate Analysis
Transform Your ScienceTransform Your Science